Diffusion Pharmaceuticals  logo
Diffusion Pharmaceuticals DFFN
$ 4.4 11.68%

Квартальный отчет 2024-Q3
добавлен 12.11.2024

report update icon

Diffusion Pharmaceuticals Мультипликаторы 2011-2024 | DFFN

Мультипликаторы по годам Diffusion Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-5.4 -0.5 -1.1 -4.3 -0.2 -0.4 -5.8 -1.8 - -3.1 -3.2 -2.8 -4.4

P/S

1.6 - - - - - - - - - 110.8 52.7 121.1

EPS

-0.8 -11.2 -12.4 -0.3 -1.8 -8.2 -3.2 -1.8 -1.3 -1 -1 -0.1 -0.2

EV (Enterprise Value)

6.51 млн 12 млн -6.87 млн 45.8 млн -7.38 млн 1.54 млн 3.99 млн 39.5 млн 7.82 млрд 27.3 млн 19.6 млн 40 млн 72.7 млн

EBITDA per Share

-2.94 -6.71 -12.1 -0.295 -1.71 -3.68 -13.6 -26.9 - -77.4 -344 -669 -1.45 тыс.

EV/EBITDA

-52.4 -2.7 1.0 0.1 0.0 -1.8 - -3.1 -1.6 -39.2 -4.3

PEG

-0.01 -0.0 -0.0 0.21 -0.0 0.0 -0.07 -0.02 - 0.03 0.0 0.0 0.0

P/B

1.6 -0.3 0.8 2.5 0.1 0.4 0.4 3.6 221.8 1.2 1.2 -1.1 -985.7

P/CF

-1.6 -1.1 -1.9 -4.5 -0.3 -0.6 -0.6 -3.0 - -4.9 -6.7 -4.5 -5.7

ROE %

-29.44 17.43 -69.02 -57.17 -58.60 -117.67 -6.43 -196.38 - -37.61 -38.16 37.25 22628.57

ROA %

-21.78 -139.57 -63.68 -51.16 -48.94 -100.92 -5.22 -103.16 - -33.55 -13.43 -279.59 -431.61

ROCE %

-105.91 10.44 -70.68 -63.16 -51.60 -69.14 -48.38 -140.82 - -19.64 -25.97 37.23 13200.00

Current Ratio

3.8 0.3 12.9 7.7 8.5 11.1 3.6 0.4 10.0 10.3 0.3 0.0 0.1

DSO

- - - - - - - - - - 10.3 69.1 -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - 1825.0 124.8

Операционный цикл

- - - - - - - - - - - 69.1 -

Финансовый цикл

- - - - - - - - - - - -1755.9 -124.8

Все данные представлены в валюте USD

Мультипликаторы поквартально Diffusion Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.55 -0.27 -0.41 - 0.65 -2.75 -1.03 - -1.7 -2.06 -2.22 - -5.99 -1.85 -2.81 - -0.07 -0.1 -0.07 - -0.6 -0.63 -0.81 - -1.99 -0.82 -4.11 - 0.21 0.88 -2.78 - -0.53 -0.37 -0.62 - -0.64 -0.06 -0.06 - -0.18 -0.35 -0.23 - -0.37 0.82 -2.91 - -0.04 -0.24 - - -0.06 -0.03 -

EBITDA per Share

- - - - - - - - -1.74 -2.08 -2.23 - -6.2 -1.86 -2.82 - -0.08 -0.06 0.05 - -0.09 -0.08 -0.09 - -0.14 -0.06 -0.08 - -0.24 -0.27 -0.25 - -0.56 -0.37 -0.62 - -0.07 -0.07 -0.06 - -0.17 -0.11 -0.2 - -0.28 -1.39 -0.36 - -0.04 -0.04 -0.03 - -0.05 -0.03 -

ROE %

-39.71 -6.83 1.86 28.10 30.88 11.19 -8.59 -27.72 -59.72 -94.48 -86.30 -48.18 -66.07 -51.97 -57.03 -40.80 -54.72 -50.76 -50.56 -39.97 -83.01 -112.13 -117.45 -81.98 -57.98 9.08 122.82 -14.86 -74.05 -157.25 -294.72 -168.39 3249.47 6726.53 9966.03 9603.42 9595.36 6169.43 2961.54 -29.19 -52.81 -68.36 -22.18 -25.62 -6.78 35.68 6.53 27.61 3050.68 6054.91 17089.46 - 3023.07 11041.74 -

ROA %

-27.66 -0.07 -38.09 -38.06 -41.41 -62.63 -34.61 -31.19 -61.04 -87.52 -80.33 -45.27 -61.28 -47.45 -51.55 -36.51 -48.14 -43.76 -42.84 -33.38 -70.29 -95.58 -100.42 -70.32 -50.82 5.59 98.76 -12.06 -43.16 -93.75 -193.49 -88.46 -150.94 -182.34 -219.04 -175.58 -183.64 -129.22 -81.16 -21.70 -30.02 -30.27 -7.06 -9.02 -150.64 -283.95 -350.79 -207.56 -325.60 -302.00 -679.07 - -118.03 -431.11 -

ROCE %

-94.39 -110.50 -101.00 -20.21 -17.37 13.41 -6.02 -27.96 -61.25 -97.38 -89.10 -49.66 -70.92 -58.88 -65.98 -24.09 -39.25 -33.15 -31.43 -42.67 -87.33 -116.84 -123.54 -85.85 -101.61 -72.71 -67.03 -41.90 -105.04 -152.43 -179.76 -172.28 3062.59 6360.60 9519.94 9218.25 9210.05 5966.98 2845.03 -23.41 -49.17 -66.73 -188.12 -183.53 -164.90 -120.50 23.50 50.06 2936.68 5804.67 7220.00 - 2886.62 1433.96 -

Current Ratio

15.1 16.6 3.0 3.8 4.9 0.2 1.9 0.3 - - - 12.9 14.9 20.7 21.9 9.5 9.5 9.5 9.5 6.1 6.1 6.1 6.1 7.0 7.0 7.0 7.0 5.3 5.3 5.3 5.3 2.1 2.1 2.1 2.1 1.0 1.0 1.0 1.0 9.3 9.3 9.3 9.3 1.5 1.5 1.5 - - - - - 1.0 0.9 1.0 -

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 22.8 45.6 - - 20.4 - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 129186.6 17022.0 397.8 - 283.7 - -

Операционный цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 22.8 45.6 - - 20.4 - -

Финансовый цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -129163.8 -16976.3 -397.8 - -263.2 - -

Все данные представлены в валюте USD